CAS RN: 90766-34-0
1-Amino-3-Bromonaphthalene
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260128
100mg / 250mg / 1g / 5g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 90766-34-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
90766-34-0 / 3-bromonaphthalen-1-amine
Standard CAS: 90766-34-0
Multi CAS: No
Basic Information
copy
CAS
90766-34-0 copy
Multi CAS
No copy
Molecular Formula
BC10H8Rn copy
Molecular Weight
222.080000 copy
Exact Mass
220.984010 copy
InChI
InChI=1S/C10H8BrN/c11-8-5-7-3-1-2-4-9(7)10(12)6-8/h1-6H,12H2 copy
InChIKey
XBAWEJDBVITLRB-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
10 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
56.06 copy
TPSA
26.02 copy
LogP / Solubility
WLOGP
3.18 copy
MLOGP
2.81 copy
XLogP3
2.7 copy
Consensus LogP
2.9 copy
Log S (ESOL)
-3.84 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.68 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.75 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.81 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy